August 21, 2014


Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate

Celgene Corporation (NASDAQ:CELG) today announced that results of a study evaluating the combination of REVLIMID® (lenalidomide) with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) in untreated diffuse large b-cell lymphoma (DLBCL) were published online ahead of print in the Journal of Clinical Oncology.

In a phase"...

Continue Reading >

August 21, 2014


Project Data Sphere, LLC Appoints Dr. Kald Abdallah, Chief Project Data Sphere Officer

Project Data Sphere, LLC has appointed Kald Abdallah, MD, PhD as Chief Project Data Sphere Officer, charging him with continuing the rapid development of which is providing broad access to cancer research databases, enabling unprecedented research collaboration to solve complex scientific problems.

“Dr. Abdallah has a track record of helping align data contributors with the innovative approach"......

Continue Reading >

August 20, 2014


Algeria to produce first insuline injection in 2015

The first insuline injection will be locally made in Algeria in 2015 in coordination with Danemark’s Novo Nordisk as part of a partnership agreement signed with Saidal in 2012.

The two parts plan to export the medecine to neighbor countries while Novo Nordisk prepares for producing insuline tablets and develop the injection.


Continue Reading >

August 20, 2014


Quintiles CEO to Present at the Morgan Stanley Global Healthcare Conference

Morgan Stanley Global Healthcare Conference

Quintiles CEO Tom Pike will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 in New York City at the Grand Hyatt Hotel.

The Quintiles presentation will begin at 9:55 a.m. (EDT). Investors may access a live audio webcast"...

Continue Reading >

August 19, 2014


First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting

  • Worldwide RE-DUAL PCITM to enroll up to 8,500 patients with atrial fibrillation who have received a coronary stent1
  • Data intended to help understand how to reduce blood clot risk and minimise bleeding risk in this patient population
  • Study is cooperatively conducted by the Harvard Clinical Research Institute and Boehringer Ingelheim

For Non-US/Non-UK/Non-Canadian Media

Boehringer Ingelheim today announces that the first"...

Continue Reading >

August 19, 2014


Expression Analysis Announces 2014 Grant Program

Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. In the sixth year of the grant program, EA and co-sponsor, Illumina, will award two fully funded oncology research grants. Each grant will enable winners to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples - focusing on a largely untapped data pool in an effort to enhance researchers’"...

Continue Reading >

August 16, 2014


Morocco calls on Algeria to cooperate in the fight against drugs

The Moroccan government called on Algeria to cooperate in the fight against drug trafficking across the Algerian-Moroccan border, rather than directing charges against Rabat which hamper efforts in this field.

This came in a statement issued by the Moroccan government yesterday in response to Algeria's statements about seizing quantities of drugs that entered the country through Morocco.


Continue Reading >

August 16, 2014


Foot-and-mouth epidemic: Vaccine distributed to seven regional laboratories

A large number of vaccine doses has been acquired by the ministry of Agriculture and Rural Development to fight against the foot-and-mouth epidemic hitting some Algerian provinces, the ministry said, adding that the vaccine has been distributed to seven regional laboratories.

According to the chief inspector of the ministry's Veterinary Department, Abdelmalek Bouhbal, the"...

Continue Reading >

August 15, 2014


Catalent Confirms the Appointment of Two Senior Healthcare Executives to Its Board of Directors

Catalent, Inc. (NYSE:CTLT), the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that it has appointed Jack Stahl and Rolf Classon to its Board of Directors.

Mr. Jack Stahl was President and Chief Executive Officer of Revlon, Inc. between 2002 and 2006. Previously, he"...

Continue Reading >

August 12, 2014


New infected with Corona virus in Tlemcen

Health Directorate of Tlemcen (Western Algeria), recorded new cases of Corona virus, as the victim was transferred quickly to hospital for treatment, where it was put under intensive care for fear of recording other cases.

Echorouk learned from well-informed medical sources, that it recorded a new case of Corona virus in Tlemcen for a public writer who recently returned from the holy sites, as analysis is currently conducted to"...

Continue Reading >